113 related articles for article (PubMed ID: 28778341)
1. [External multicentric validation of two scores predicting the risk of relapse in patients with borderline ovarian tumors: The nomogram of Bendifallah and the score of Ouldamer].
Pais P; Huchon C; Chevrot A; Cohen J; Fauconnier A; Rouzier R; Mimouni M
Bull Cancer; 2017 Sep; 104(9):721-726. PubMed ID: 28778341
[TBL] [Abstract][Full Text] [Related]
2. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
[TBL] [Abstract][Full Text] [Related]
3. Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors.
Bendifallah S; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
Am J Obstet Gynecol; 2014 Dec; 211(6):637.e1-6. PubMed ID: 24949545
[TBL] [Abstract][Full Text] [Related]
4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
[TBL] [Abstract][Full Text] [Related]
5. External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours.
Bendifallah S; Uzan C; Fauvet R; Morice P; Darai E
Br J Cancer; 2013 Nov; 109(11):2774-7. PubMed ID: 24169360
[TBL] [Abstract][Full Text] [Related]
6. Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors.
Obermair A; Tang A; Kondalsamy-Chennakesavan S; Ngan H; Zusterzeel P; Quinn M; Carter J; Leung Y; Janda M
Int J Gynecol Cancer; 2013 Feb; 23(2):264-7. PubMed ID: 23295940
[TBL] [Abstract][Full Text] [Related]
7. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
8. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
9. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
[TBL] [Abstract][Full Text] [Related]
10. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.
Jones BP; Saso S; Farren J; El-Bahrawy M; Ghaem-Maghami S; Smith JR; Yazbek J
Int J Gynecol Cancer; 2017 Nov; 27(9):1813-1818. PubMed ID: 28763365
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors.
Zanetta G; Rota S; Lissoni A; Meni A; Brancatelli G; Buda A
Gynecol Oncol; 2001 Apr; 81(1):63-6. PubMed ID: 11277651
[TBL] [Abstract][Full Text] [Related]
13. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors.
Helpman L; Beiner ME; Aviel-Ronen S; Perri T; Hogen L; Jakobson-Setton A; Ben-Baruch G; Korach J
Fertil Steril; 2015 Jul; 104(1):138-44. PubMed ID: 25956371
[TBL] [Abstract][Full Text] [Related]
14. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy.
Ødegaard E; Staff AC; Langebrekke A; Engh V; Onsrud M
Acta Obstet Gynecol Scand; 2007; 86(5):620-6. PubMed ID: 17464594
[TBL] [Abstract][Full Text] [Related]
15. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
[TBL] [Abstract][Full Text] [Related]
17. Is there a justification for hysterectomy in patients with borderline ovarian tumors?
Ouldamer L; Lacoste C; Cormier B; Arbion F; Marret H; Jallais L; Fignon A; Body G
Surg Oncol; 2016 Mar; 25(1):1-5. PubMed ID: 26979634
[TBL] [Abstract][Full Text] [Related]
18. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
19. Ovarian serous borderline tumors with invasive peritoneal implants.
Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
[TBL] [Abstract][Full Text] [Related]
20. Management of low-grade serous ovarian neoplasm in the setting of fertility preservation.
Marchocki Z; Rouzbahman M; Chawla T; May T
Int J Gynecol Cancer; 2020 Nov; 30(11):1834-1839. PubMed ID: 32759183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
